ALX Oncology Holdings Inc — Quarterly Financial Statistics (NASDAQ:ALXO) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics

Quarterly Annual

Cash from operating activities -32.05 M-24.66 M-23.41 M-17.09 M-18.98 M -84.14 M Cash from investing activities 33.18 M27.64 M22.32 M21.39 M11.23 M 82.59 M Cash from financing activities 328 K65 K-222 K-159 K678 K 362 K Free cash flow -32.11 M-24.72 M-23.45 M-17.15 M-19.03 M -84.35 M

Nouvelles

ALX Oncology nomme Jeff Knight au poste de directeur du développement

Wells Fargo initie la couverture d’ALX Oncology avec surpondération

ALDX Crashes 71% as FDA Issues Third CRL for Dry Eye Disease Drug NDA

CTMX Stock Rallies on Strong Phase I Colorectal Cancer Study Data

IBRX Stock Jumps on Progress in NK Cell Therapy Production

JNJ's Bladder Cancer Therapy Meets Key Goal in Early-Stage Study

RARE's DTX301 Meets First Key Goal in Phase III OTC Deficiency Study

RLMD Stock Surges 42% in a Week: Here's What You Should Know

GSK Out-Licenses Rights for Rare Liver Disease Drug to Alfasigma

EDIT Stock Up on Narrower-Than-Expected Q4 Loss, Revenues Rise Y/Y

Roche's Giredestrant Misses Key Goal in First-Line Breast Cancer Study

LRMR Stock on the Move: What Sparked the 55% Jump in the Past Month?